🇺🇸 FDA
Patent

US 10350273

Treatment of hormonal disorders of growth

granted A61KA61K31/352A61K31/437

Quick answer

US patent 10350273 (Treatment of hormonal disorders of growth) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/352, A61K31/437, A61K31/473, A61K31/48